Who owns Adverum Biotechnologies, Inc.?

Tip: Access positions for across all investors

Analyze quarterly positions in Adverum Biotechnologies with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Adverum Biotechnologies stock

Who bought or sold Adverum Biotechnologies, Inc. this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
BML Capital Management 3.1M $14M 0% Sep 2025
 View chart
Frazier Life Sciences Management 2.1M $9.4M 94% Sep 2025
 View chart
Principia Wealth Advisory 2.0M $4.4M 20% Jun 2025
 View chart
TCG Crossover Management 1.7M $7.6M -7% Sep 2025
 View chart
Vanguard Group 872k $4.0M -1% Sep 2025
 View chart
5AM Venture Management 542k $2.5M 0% Sep 2025
 View chart
Goldman Sachs Group 403k $1.8M -13% Sep 2025
 View chart
Renaissance Technologies 364k $1.6M -36% Sep 2025
 View chart
Pale Fire Capital SE 363k $1.6M 1% Sep 2025
 View chart
Millennium Management 324k $1.5M -5% Sep 2025
 View chart
BlackRock 311k $1.4M -25% Sep 2025
 View chart
Soleus Capital Management 287k $1.3M 0% Sep 2025
 View chart
Dimensional Fund Advisors 235k $1.1M -18% Sep 2025
 View chart
Geode Capital Management 185k $837k 0% Sep 2025
 View chart
Regeneron Pharmaceuticals 181k $820k 0% Sep 2025
 View chart
Warren Averett Asset Management 161k $729k 0% Sep 2025
 View chart
Two Sigma Investments 89k $402k 373% Sep 2025
 View chart
State Street Corporation 69k $311k 0% Sep 2025
 View chart
Susquehanna International 58k $260k -3% Sep 2025
 View chart
Morgan Stanley 53k $114k 100% Jun 2025
 View chart
Quinn Opportunity Partners 41k $188k 0% Sep 2025
 View chart
Citadel Advisors 41k $187k -47% Sep 2025
 View chart
Two Sigma Advisers 38k $173k 256% Sep 2025
 View chart
Marshall Wace 28k $129k -43% Sep 2025
 View chart
Northern Trust 28k $127k -18% Sep 2025
 View chart
Qube Research & Technologies 22k $98k -29% Sep 2025
 View chart
D. E. Shaw & Co 17k $78k -36% Sep 2025
 View chart
Royal Bank of Canada 14k $50k 386% Sep 2025
 View chart
JustInvest 13k $58k 100% Sep 2025
 View chart
XTX Topco 13k $57k -57% Sep 2025
 View chart
Squarepoint Ops 11k $51k -48% Sep 2025
 View chart
UBS Group 5.6k $25k -61% Sep 2025
 View chart
FMR 1.9k $8.8k -17% Sep 2025
 View chart
Advisor Group Holdings 1.7k $7.7k 0% Sep 2025
 View chart
Jones Financial Companies, L.L 1.0k $4.5k 0% Sep 2025
 View chart
Bnp Paribas Arbitrage, Snc 540.00 $2.4k -31% Sep 2025
 View chart
UMA Financial Services 217.00 $984.008200 100% Sep 2025
 View chart
Jpmorgan Chase & Co 182.00 $824.005000 -98% Sep 2025
 View chart
Hanson McClain Advisors 102.00 $462.998400 0% Sep 2025
 View chart
SBI Securities 84.00 $380.998800 0% Sep 2025
 View chart
Parallel Advisors 50.00 $227.000000 0% Sep 2025
 View chart
CWM 33.00 $0 -98% Sep 2025
 View chart
Wells Fargo & Company 30.00 $135.999000 -86% Sep 2025
 View chart
Barclays 21.00 $95.999400 100% Sep 2025
 View chart
GHP Investment Advisors 20.00 $91.000000 0% Sep 2025
 View chart
SRS Capital Advisors 19.00 $85.999700 100% Sep 2025
 View chart
Sound Income Strategies 1.00 $5.000000 100% Sep 2025
 View chart
Deutsche Bank Aktiengesellschaft 1.00 $5.000000 0% Sep 2025
 View chart

Who sold out of Adverum Biotechnologies?

Fund or Company Name Date Sold Shares Held Valued At
Jane Street Jun 2025 71k $153k
Readystate Asset Management Jun 2025 68k $145k
Hrt Financial Jun 2025 31k $65k
Jain Global Jun 2025 22k $47k
Y-Intercept Jun 2025 21k $45k
Point72 Asia Jun 2025 15k $31k
American Century Companies Jun 2025 11k $23k
Captrust Financial Advisors Jun 2025 10k $22k
Tower Research Capital Jun 2025 2.1k $4.6k
Cubist Systematic Strategies Jun 2025 1.9k $4.1k
Raymond James Financial Jun 2025 1.0k $2.2k
Point72 Jun 2025 225.00 $483.997500
Eq Wealth Advisors Jun 2025 162.00 $347.992200
NISA Investment Advisors Jun 2025 84.00 $181.003200